Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma

Published:2016-02-19 Issue:4 Volume:63 Page:1213-1226
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Iwagami Yoshifumi¹,Huang Chiung-Kuei¹,Olsen Mark J.²,Thomas John-Michael²,Jang Grace²,Kim Miran¹,Lin Qiushi³,Carlson Rolf I.¹,Wagner Carl E.⁴,Dong Xiaoqun³,Wands Jack R.¹

Affiliation:

1. Division of Gastroenterology & Liver Research Center; Warren Alpert Medical School of Brown University and Rhode Island Hospital; Providence RI

2. Department of Medical Chemistry, College of Pharmacy Glendale; Midwestern University; Glendale AZ

3. Department of Internal Medicine, College of Medicine; The University of Oklahoma Health Sciences Center; Oklahoma City OK

4. Arizona State University; Glendale AZ

Funder

National Institutes of Health

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.28411/fullpdf

Reference44 articles.

1. Global cancer statistics in the year 2000;Parkin;Lancet Oncol,2001

2. Hepatocellular carcinoma;El-Serag;N Engl J Med,2011

3. Medical therapies for hepatocellular carcinoma: a critical view of the evidence;Villanueva;Nat Rev Gastroenterol Hepatol,2013

4. cDNA cloning and expression of bovine aspartyl (asparaginyl) beta-hydroxylase;Jia;J Biol Chem,1992

5. EGF-like domains in extracellular matrix proteins: localized signals for growth and differentiation?;Engel;FEBS Lett,1989

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 10-hydroxy-2-decenoic acid prevents osteoarthritis by targeting aspartyl β hydroxylase and inhibiting chondrocyte senescence in male mice preclinically;Nature Communications;2024-09-04

2. A cellular senescence-related signature for predicting prognosis, immunotherapy response, and candidate drugs in patients treated with transarterial chemoembolization (TACE);Discover Oncology;2024-07-08

3. The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma;Cancer Letters;2024-07

4. CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2024-05

5. Inhibition of endogenous hydrogen sulfide production reduces activation of hepatic stellate cells via the induction of cellular senescence;Cell Cycle;2024-03-18